These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 4070392)

  • 41. AMN082, a metabotropic glutamate receptor 7 allosteric agonist, attenuates locomotor sensitization and cross-sensitization induced by cocaine and morphine in mice.
    Jenda M; Gawel K; Marszalek M; Komsta L; Kotlinska JH
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Mar; 57():166-75. PubMed ID: 25448778
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of opiate antagonists and their quaternary derivatives on heroin self-administration in the rat.
    Koob GF; Pettit HO; Ettenberg A; Bloom FE
    J Pharmacol Exp Ther; 1984 May; 229(2):481-6. PubMed ID: 6716270
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Naltrexone blocks the expression of the conditioned elevation of natural killer cell activity in BALB/c mice.
    Solvason HB; Hiramoto RN; Ghanta VK
    Brain Behav Immun; 1989 Sep; 3(3):247-62. PubMed ID: 2482096
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Central vs. peripheral mediation of opioid effects on alcohol consumption in free-feeding rats.
    Linseman MA
    Pharmacol Biochem Behav; 1989 Jun; 33(2):407-13. PubMed ID: 2813479
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Relationship between behavioral and nociceptive changes in attacked mice: effects of opiate antagonists.
    Frischknecht HR; Siegfried B
    Psychopharmacology (Berl); 1989; 97(2):160-2. PubMed ID: 2498922
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of nor-binaltorphimine on the development of analgesic tolerance to and physical dependence on morphine.
    Suzuki T; Narita M; Takahashi Y; Misawa M; Nagase H
    Eur J Pharmacol; 1992 Mar; 213(1):91-7. PubMed ID: 1499660
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Limitations on the antagonistic actions of opioid antagonists.
    Young AM; Woods JH
    Fed Proc; 1982 May; 41(7):2333-8. PubMed ID: 7042396
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antagonism of the behavioral effects of ethanol by naltrexone in BALB/c, C57BL/6, and DBA/2 mice.
    Kiianmaa K; Hoffman PL; Tabakoff B
    Psychopharmacology (Berl); 1983; 79(4):291-4. PubMed ID: 6407041
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Modulation of opioid system in C57 mice after repeated treatment with morphine and naloxone: biochemical and behavioral correlates.
    Brunello N; Volterra A; Di Giulio AM; Cuomo V; Racagni G
    Life Sci; 1984 Apr; 34(17):1669-78. PubMed ID: 6328141
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Brain areas involved in production of morphine-induced locomotor hyperactivity of the C57B1/6J mouse.
    Stevens KE; Mickley GA; McDermott LJ
    Pharmacol Biochem Behav; 1986 Jun; 24(6):1739-47. PubMed ID: 3737639
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of the dorsal raphe nucleus in morphine-induced immediate early gene expression in the rat striatum.
    Frankel PS; Harlan RE; Garcia MM
    Brain Res; 1999 Sep; 842(1):220-3. PubMed ID: 10526114
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An analysis of the paradoxical effect of morphine on runway speed and food consumption.
    Corrigall WA; Linseman MA; D'Onofrio RM; Lei H
    Psychopharmacology (Berl); 1986; 89(3):327-33. PubMed ID: 3088658
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Methylnaltrexone prevents morphine-induced delay in oral-cecal transit time without affecting analgesia: a double-blind randomized placebo-controlled trial.
    Yuan CS; Foss JF; O'Connor M; Toledano A; Roizen MF; Moss J
    Clin Pharmacol Ther; 1996 Apr; 59(4):469-75. PubMed ID: 8612393
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Monoamine metabolism in the locus coeruleus measured concurrently with behavior during opiate withdrawal: an in vivo microdialysis study in freely moving rats.
    Javelle N; Renaud B; Lambás-Señas L
    J Neurochem; 1997 Feb; 68(2):683-90. PubMed ID: 9003056
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An antiabsorptive basis for precipitated withdrawal diarrhea in morphine-dependent rats.
    Chang EB; Brown DR; Field M; Miller RJ
    J Pharmacol Exp Ther; 1984 Feb; 228(2):364-9. PubMed ID: 6607339
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Involvement of substance P and central opioid receptors in morphine modulation of the CHS response.
    Nelson CJ; Lysle DT
    J Neuroimmunol; 2001 Apr; 115(1-2):101-10. PubMed ID: 11282159
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intraseptally injected opiate agents: effects on morphine-induced behaviour of cats.
    Megens AA; Cools AR
    Pharmacol Biochem Behav; 1982 Aug; 17(2):297-304. PubMed ID: 6291068
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Stress- and morphine-induced elevations of plasma and tissue cholesterol in mice: reversal by naltrexone.
    Bryant HU; Kuta CC; Story JA; Yim GK
    Biochem Pharmacol; 1988 Oct; 37(19):3777-80. PubMed ID: 3178891
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antagonism of the antinociceptive and discriminative stimulus effects of heroin and morphine by 3-methoxynaltrexone and naltrexone in rhesus monkeys.
    Bowen CA; Fischer BD; Mello NK; Negus SS
    J Pharmacol Exp Ther; 2002 Jul; 302(1):264-73. PubMed ID: 12065726
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Simultaneous development of opioid tolerance and opioid antagonist-induced receptor upregulation.
    Yoburn BC; Sierra V; Lutfy K
    Brain Res; 1990 Oct; 529(1-2):143-8. PubMed ID: 2178026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.